Helix BioPharma Corp. (TSE:HBP – Get Free Report) shares passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$0.93 and traded as high as C$0.98. Helix BioPharma shares last traded at C$0.98, with a volume of 5,000 shares changing hands.
Helix BioPharma Price Performance
The stock has a fifty day moving average price of C$0.93 and a 200-day moving average price of C$0.96. The company has a market cap of C$51.96 million, a PE ratio of -1.03 and a beta of -0.84.
About Helix BioPharma
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
Further Reading
- Five stocks we like better than Helix BioPharma
- How to buy stock: A step-by-step guide for beginnersÂ
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How to Effectively Use the MarketBeat Ratings Screener
- DuPont’s Electronics Spinoff: The Start of Something Big
- With Risk Tolerance, One Size Does Not Fit All
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Helix BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
